ARHGAP20 Antikörper (Middle Region)
Kurzübersicht für ARHGAP20 Antikörper (Middle Region) (ABIN928960)
Target
Alle ARHGAP20 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Aufreinigung
- Purified
-
Immunogen
- ARHGAP20 antibody was raised in rabbit using the middle region of ARHGAP20 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
ARHGAP20 Blocking Peptide, (ABIN936228), is also available for use as a blocking control in assays to test for specificity of this ARHGAP20 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ARHGAP20 (rho GTPase Activating Protein 20 (ARHGAP20))
-
Andere Bezeichnung
- ARHGAP20
-
Hintergrund
- ARHGAP20 is an GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. Synonyms: Polyclonal ARHGAP20 antibody, Anti-ARHGAP20 antibody, Rho GTPase activating protein 20 antibody, KIAA1391 antibody, RARHOGAP antibody.
Target
-